# Prophylactic Use of Hydroxycobolamin in Vasoplegic Syndrome in Adult Patients Undergoing Cardiopulmonary Bypass

> **NCT06160219** · PHASE2,PHASE3 · COMPLETED · sponsor: **Ain Shams University** · enrollment: 60 (actual)

## Conditions studied

- Vasoplegic Syndrome

## Interventions

- **DRUG:** Hydroxycobalamin

## Key facts

- **NCT ID:** NCT06160219
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-08-28
- **Primary completion:** 2023-11-20
- **Final completion:** 2023-11-27
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2024-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06160219

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06160219, "Prophylactic Use of Hydroxycobolamin in Vasoplegic Syndrome in Adult Patients Undergoing Cardiopulmonary Bypass". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06160219. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*